Zhu Hongwei, Zhang Yunyi, Zhang Jianwen, Chen Daofeng
School of Pharmacy, Fudan University, Shanghai 200032, People's Republic of China.
Int Immunopharmacol. 2008 Sep;8(9):1222-30. doi: 10.1016/j.intimp.2008.04.012. Epub 2008 May 27.
EWDS-1, a homogeneous protein-bound polysaccharide, was isolated as an anti-complementary agent from the stem barks of Eucommia ulmoides. EWDS-1 was identified as a branched proteoglycan with average molecular weight about 2,000,000 Da, composed of Gal, Glc and Ara in the ratio of 2.1:1.0:0.9, along with trace of Rha, Xyl, Man, as well as 3.95% of protein. The linkages of the residues of EWDS-1 were deduced by methylation analysis and NMR technique. Bioassay showed that EWDS-1 inhibited complement activation on both the classic and alternative pathways with CH(50) and AP(50) values of 203+/-20 microg/ml and 45+/-8 microg/ml, respectively. Preliminary mechanism studies by using complement component depleted-sera indicated that EWDS-1 inhibits activation of complement system by interacting with C1q, C1r, C1s, C2, C3, C4, C5 and C9. The results suggested that EWDS-1 could be of promising benefits in treatment of the complement associated diseases.
杜仲水溶性多糖-1(EWDS-1)是一种均质的蛋白结合多糖,从杜仲茎皮中分离得到,具有抗补体活性。EWDS-1被鉴定为一种分支蛋白聚糖,平均分子量约为2,000,000 Da,由半乳糖(Gal)、葡萄糖(Glc)和阿拉伯糖(Ara)按2.1:1.0:0.9的比例组成,还含有微量的鼠李糖(Rha)、木糖(Xyl)、甘露糖(Man)以及3.95%的蛋白质。通过甲基化分析和核磁共振技术推断出EWDS-1残基的连接方式。生物活性测定表明,EWDS-1对经典途径和替代途径的补体激活均有抑制作用,其CH(50)和AP(50)值分别为203±20 μg/ml和45±8 μg/ml。利用补体成分缺失血清进行的初步机制研究表明,EWDS-通过与C1q、C1r、C1s、C2、C3、C4、C5和C9相互作用来抑制补体系统的激活。结果表明,EWDS-1在治疗补体相关疾病方面可能具有良好的应用前景。